ALLO
Allogene Therapeutics Inc
1.50$
+4.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.7% | +2.2% | +2.5% | -12.0% | +0.8% | -4.1% | +0.2% | -0.3% | -1.3% | -6.1% | -7.8% | – | |
| – | -0.8% | -21.7% | +13.7% | -1.3% | -3.8% | -5.4% | -28.7% | -0.4% | -6.0% | +1.7% | +50.4% | – | |
| – | – | – | – | – | -75.1% | -257.4% | – | – | – | – | -103.1% | – | |
| – | +1,408.3% | -95.6% | -100.0% | – | -40.1% | -61.5% | -55.6% | +452.3% | -100.0% | – | +1,566.7% | – | |
| – | – | -67.2% | +237.1% | -201.8% | – | -88.8% | +609.8% | -72.8% | +181.6% | -188.0% | +398.7% | – | |
| – | – | -65.2% | – | – | – | – | – | – | – | – | +0.0% | – | |
| – | -96.4% | +964.5% | +6,482.0% | -99.4% | +745.8% | +143.6% | -63.7% | -36.2% | +142.9% | +168.8% | +789.5% | – | |
| – | – | -330.9% | – | -199.8% | – | -236.6% | – | -247.0% | – | -254.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.